SHL Medical, a company specializing in the design, development, and manufacturing of self-injection solutions, has officially inaugurated its new manufacturing facility in North Charleston, South Carolina.
The new facility will manufacture SHL Medical’s autoinjectors, which are used in medications in areas such as endocrine and metabolic disorders (including GLP-1 therapies), dermatology, musculoskeletal diseases, and other therapy areas. It ensures a reliable supply of these devices to millions of patients worldwide.
The fully automated 360,000-square-foot facility represents a $220 million investment and has already created more than 300 local jobs. Equipped with medical device injection molding technology and fully automated assembly capabilities, the site ensures precision, efficiency, and quality in SHL Medical’s advanced drug delivery solutions.
By leveraging its existing final assembly, labeling, and packaging operations in Deerfield Beach, Florida, and integrating recent acquisitions under SHL Advantec, the North Charleston facility enhances SHL Medical’s US presence and solidifies its leadership in large-scale autoinjector production. The company is on track to deliver 1.5 billion devices to customers in 2025.